Glyn Edwards takes chairman role at UK oncolytic virus startup emerging out of stealth

Oncolytic viruses — viruses that can selectively replicate in cancer cells and kill them — have been steadily attracting investment and curiosity. However, for the most part, those candidates have not quite panned out to the extent their backers hope.

But now, one new biotech claims it can actually meet...

Click to view original post